Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles

References

• Bicker J, Alves G, Fortuna A, Falcao A. Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review. Eur J Pharm Biopharm 2014;87:409–32
   PubMed Web of Science ®Google Scholar
• Krol S. Challenges in drug delivery to the brain: nature is against us. J Control Release 2012;164:145–55
   PubMed Web of Science ®Google Scholar
• Amoozgar Z, Wang L, Brandstoetter T, et al. Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer model. Biomacromolecules 2014;15:4187–94
   PubMed Web of Science ®Google Scholar
• Mo L, Hou L, Guo D, et al. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells. Int J Pharm 2012;436:815–24
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, et al. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 2012;161:505–22
   PubMed Web of Science ®Google Scholar
• Zarschler K, Prapainop K, Mahon E, et al. Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies. Nanoscale 2014;6:6046–56
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang YF, Bryant J, et al. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin Cancer Res 2004;10:3667–77
   PubMed Web of Science ®Google Scholar
• Pushparaj PN, Melendez AJ. Short interfering RNA (siRNA) as a novel therapeutic. Clin Exp Pharmacol Physiol 2006;33:504–10
   PubMed Web of Science ®Google Scholar
• de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 2007;6:443–53
   PubMed Web of Science ®Google Scholar
• Khan M, Ong ZY, Wiradharma N, et al. Advanced materials for co-delivery of drugs and genes in cancer therapy. Adv Healthc Mater 2012;1:373–92
   PubMed Web of Science ®Google Scholar
• Liu S, Guo Y, Huang R, et al. Gene and doxorubicin co-delivery system for targeting therapy of glioma. Biomaterials 2012;33:4907–16
   PubMed Web of Science ®Google Scholar
• Mignani S, Bryszewska M, Klajnert-Maculewicz B, et al. Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report. Biomacromolecules 2014;16:1–27
   PubMed Web of Science ®Google Scholar
• Huang HY, Kuo WT, Chou MJ, Huang YY. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression. J Biomed Mater Res Part A 2011;97A:330–8
   Web of Science ®Google Scholar
• Liu CW, Lin WJ. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells. J Drug Target 2013;21:776–86
   PubMed Web of Science ®Google Scholar
• Skandrani N, Barras A, Legrand D, et al. Lipid nanocapsules functionalized with polyethyleneimine for plasmid DNA and drug co-delivery and cell imaging. Nanoscale 2014;6:7379–90
   PubMed Web of Science ®Google Scholar
• Wang H, Su W, Wang S, et al. Smart multifunctional core-shell nanospheres with drug and gene co-loaded for enhancing the therapeutic effect in a rat intracranial tumor model. Nanoscale 2012;4:6501–8
   PubMed Web of Science ®Google Scholar
• Presumey J, Salzano G, Courties G, et al. PLGA microspheres encapsulating siRNA anti-TNFalpha: efficient RNAi-mediated treatment of arthritic joints. Eur J Pharm Biopharm 2012;82:457–64
   PubMed Web of Science ®Google Scholar
• Yuan X, Shah BA, Kotadia NK, et al. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery. Pharm Res 2010;27:1285–95
   PubMed Web of Science ®Google Scholar
• Demeule M, Currie JC, Bertrand Y, et al. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2. J Neurochem 2008;106:1534–44
   PubMed Web of Science ®Google Scholar
• Demeule M, Regina A, Che C, et al. Identification and design of peptides as a new drug delivery system for the brain. J Pharmacol Exp Ther 2008;324:1064–72
   PubMed Web of Science ®Google Scholar
• Maletinska L, Blakely EA, Bjornstad KA, et al. Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein. Cancer Res 2000;60:2300–3
   PubMed Web of Science ®Google Scholar
• Drappatz J, Brenner A, Wong ET, et al. Phase I study of GRN1005 in recurrent malignant glioma. Clin Cancer Res 2013;19:1567–76
   PubMed Web of Science ®Google Scholar
• Betancourt T, Brown B, Brannon-Peppas L. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomedicine (Lond) 2007;2:219–32
   PubMed Web of Science ®Google Scholar
• Cao N, Cheng D, Zou S, et al. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Biomaterials 2011;32:2222–32
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402–8
   PubMed Web of Science ®Google Scholar
• Wang L, Shi JJ, Jia X, et al. NIR-/pH-responsive drug delivery of functionalized single-walled carbon nanotubes for potential application in cancer chemo-photothermal therapy. Pharmaceut Res 2013;30:2757–71
   PubMed Web of Science ®Google Scholar
• Wang L, Shi J, Zhang H, et al. Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes. Biomaterials 2013;34:262–74
   PubMed Web of Science ®Google Scholar
• Jiang X, Dai H, Leong KW, et al. Chitosan-g-PEG/DNA complexes deliver gene to the rat liver via intrabiliary and intraportal infusions. J Gene Med 2006;8:477–87
   PubMed Web of Science ®Google Scholar
• Yang F, Huang W, Li Y, et al. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles. Biomaterials 2013;34:5689–99
   PubMed Web of Science ®Google Scholar
• Chan P, Kurisawa M, Chung JE, Yang YY. Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery. Biomaterials 2007;28:540–9
   PubMed Web of Science ®Google Scholar
• Chen H, Yang W, Chen H, et al. Surface modification of mitoxantrone-loaded PLGA nanospheres with chitosan. Colloids Surf B Biointerfaces 2009;73:212–18
   PubMed Web of Science ®Google Scholar
• Wong K, Sun G, Zhang X, et al. PEI-g-chitosan, a novel gene delivery system with transfection efficiency comparable to polyethylenimine in vitro and after liver administration in vivo. Bioconjug Chem 2006;17:152–8
   PubMed Web of Science ®Google Scholar
• Lin R, Shi NL, Wang CH. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. Biomaterials 2005;26:4476–85
   PubMed Web of Science ®Google Scholar
• Park J, Fong PM, Lu J, et al. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. Nanomedicine 2009;5:410–18
   PubMed Web of Science ®Google Scholar
• Amjadi I, Rabiee M, Hosseini MS, Mozafari M. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system. Appl Biochem Biotechnol 2012;168:1434–47
   PubMed Web of Science ®Google Scholar
• Lu YJ, Wei KC, Ma CC, et al. (2012) Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes. Colloids Surf B Biointerfaces 2012;89:1–9
   PubMed Web of Science ®Google Scholar
• Kaneshiro TL, Lu Z. Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. Biomaterials 2009;30:5660–6
   PubMed Web of Science ®Google Scholar
• Guo M, Rong WT, Hou J, et al. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin. Nanotechnology 2013;24:1–15
   Google Scholar
• Pardridge WM. Non-invasive drug delivery to the human brain using endogenous blood–brain barrier transport systems. Pharm Sci Technol Today 1999;2:49–59
   PubMedGoogle Scholar
• Xiao K, Li Y, Luo J, et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 2011;32:3435–46
   PubMed Web of Science ®Google Scholar
• Patil RR, Yu J, Banerjee SR, et al. Probing in vivo trafficking of polymer/DNA micellar nanoparticles using SPECT/CT imaging. Mol Ther 2011;19:1626–35
   PubMed Web of Science ®Google Scholar
• Li W, Wu C, Yao Y, et al. MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression. Neurosci Lett 2014;566:82–7
   PubMed Web of Science ®Google Scholar
• Parker JJ, Dionne KR, Massarwa R, et al. Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastoma. Neuro Oncol 2013;15:1048–57
   PubMed Web of Science ®Google Scholar
• Shi J, Zhang H, Wang L, et al. PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor. Biomaterials 2013;34:251–61
   PubMed Web of Science ®Google Scholar